Effects of theophylline on chronic inflammatory lung injury induced by LPS exposure in guinea pigs

Allergology International

Volumn 56, Issue 4, 2007, Pages 445-456

  Kaneko, Yoshio ^a   Takashima, Kazumi ^a   Suzuki, Naomi ^a   Yamana, Kenjiro ^a  

^a Kowa Company Limited   (Japan)

Author keywords

Airway hyperreactivity; COPD; Goblet cell hyperplasia; Lipopolysaccharide exposure; Theophylline

Indexed keywords

DEXAMETHASONE; HYDROXYPROLINE; LIPOPOLYSACCHARIDE; THEOPHYLLINE;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CELL HYPERPLASIA; CELL INFILTRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; GOBLET CELL; GUINEA PIG; HISTOLOGY; INFLAMMATORY CELL; LEUKOCYTE; LUNG; LUNG ALVEOLUS; LUNG ALVEOLUS WALL; LUNG PARENCHYMA; MALE; NEBULIZATION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SWELLING;

EID: 37349073829     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-07-490     Document Type: Article

References (46)

1. Kallos P, Kallos L. Experimental asthma in guinea pig revisited. Int. Arch. Allergy Appl. Immunol. 1984;73:77-85.
2. Shinagawa K, Kojima M. Mouse model of airway remodeling. Am. J. Respir. Crit. Care Med. 2003;168:959-967.
3. Huston PA, Church MK, Clay TP, Miller P, Holgate ST. Early and late-phase bronchoconstriction after allergen challenge of nonanesthetized guinea pigs. I. The association of disordered airway physiology to leukocyte infiltration. Am. Rev. Respir. Dis. 1988;137:548-557.
4. Savov JD, Brass DM, Berman KG, McElvania E, Schwartz DA. Fibrinolysis in LPS-induced chronic airway disease. Am. J. Physiol. Lung Cell Mol. Physiol. 2003;285:L940-948.
5. Vernooy JH, Dentener MA, van Suylen RJ, Buurman WA, Wouters EF. Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology. Am. J. Respir. Cell Mol. Biol. 2002;26:152-159.
6. Snella MC, Rylander R. Lung cell reactions after inhalation of bacterial lipopolysaccharides. Eur. J. Respir. Dis. 1982;63:550-557.
7. Brass DM, Savov JD, Whitehead GS, Maxwell DA, Schwartz DA. LPS binding protein is important in the airway response to inhaled endotoxin. J. Allergy Clin. Immunol. 2004;114:586-592.
8. Roth J, McClellan JL, Kluger MJ, Zeisberger E. Attenuation of fever and release of cytokines after repeated injections of lipopolysaccharide in guinea-pigs. J. Physiol. 1994;477:177-185.
9. Toward TJ, Broadler KJ. Goblet cell hyperplasia, airway function, and leukocyte infiltration after chronic lipopolysaccharide exposure in conscious Guinea pigs: effects of rolipram and dexamethasone. J. Pharmacol. Exp. Ther. 2002;302:814-821.
10. Toward TJ, Broadler KJ. Chronic lipopolysaccharide exposure on airway function, cell infiltration, and nitric oxide generation in conscious guinea pigs: effect of rolipram and dexamethasone. J. Pharmacol. Exp. Ther. 2001;298: 298-306.
11. Rietschel ET, Kirikae T, Schade FU et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 1994;8:217-225.
12. Hele D. First Siena International Conference on animal models of chronic obstructive pulmonary disease, Certosa di Pontignano, University of Siena, Italy, September 30-October2, 2001. Respir. Res. 2002;3:12.
13. Ofulue AF, Mary KO, Abboud RT. Time course of neutrophil and macrophage elastinolytic activities in cigarette smoke-induced emphysema. Am. J. Physiol. Lung Cell Mol. Physiol. 1998;19:L1134-1144.
14. Kobayashi T. Exposure to diesel exhaust aggravates nasal allergic reaction in guinea pigs. Am. J. Respir. Crit. Care Med. 2000;162:352-356.
15. Ekimoto H, Takada K, Ohnuki T et al. Different sensitivity to bleomycin-induced pulmonary fibrosis among various strains of mice. J. Clin. Biochem. Nutr. 1987;2:25-31.
16. Coker RK, Laurent GJ, Shahzeidi S et al. Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am. J. Pathol. 1997;159:981-991.
17. Kuhn C, Yu SY, Chrapyvy M, Linder HE, Senior RM. The induction of emphysema with elastase. II. Changes in connective tissue. Lab. Invest. 1976;34:372-380.
18. Onclinx C, De Maertelaer V, Gustin P, Gevenois PA. Elastase-induced pulmonary emphysema in rats: comparison of computed density and microscopic morphometry. Radiology 2006;241:763-770.
19. Gharase KM, Ullenbruch M, Phan SH. Animal models of pulmonary fibrosis. Methods Mol. Med. 2005;117:251-259.
20. Hsueh W, Sun X, Rioja LN, Gonzalez-Crussi F. The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin. Immunology 1990;70:309-314.
21. Chignard M, Balloy V. Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. Am. J. Physiol. Lung Cell Mol. Physiol. 2000;279:L1083-1090.
22. Severgnini M, Takahashi S, Rozo LM et al. Activation of the STAT pathway in acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2004;286:L1282-1292.
23. Brower RG, Ware LB, Berthiaume Y, Matthay MA. Treatment of ARDS. Chest 2001;120:1347-1367.
24. Trop M, Schiffrin EJ, Carter EA. Effect of acute and chronic lipopolysaccharide (LPS) administration on reticuloendothelial system (RES) phagocytic activity in vivo. Burns. 1992;18:107-108.
25. Leikauf GD, Borchers MT, Prows DR, Simpson LG. Mucin apoprotein expression in COPD. Chest 2002;121: 166S-182S.
26. Rogers DF. Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy. Monaldi. Arch. Chest Dis. 2000;55:324-332.
27. Barnes PJ. Mechanisms in COPD: differences from asthma. Chest 2000;117:10S-14S.
28. Nagai A. Pathology and pathophysiology of chronic obstructive pulmonary disease. Intern. Med. 2002;41:265-269.
29. Burns PJ. Theophylline in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2005;2:334-339.
30. Kosmas EN, Michaelides SA, Polychronaki A et al. Theophylline induces a reduction in circulating interleukin-4 and interleukin-5 in atopic asthmatics. Eur. Respir. J. 1999;13:53-58.
31. Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM, Barnes PJ. Theophylline restores histon deacetylase activity and steroid responses in COPD macrophages. J. Exp. Med. 2004;200:689-695.
32. Global Initiative for Chronic Obstructive Disease (GOLD) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Workshop Report 2006.
33. Konzett H, Rossler R. Versuchsanordung zu untersuchungen an der bronchial muskulatur, naunyn-schmiedeb. Arch. Exp. Pathol. Pharmakol. 1940;195:71.
34. Whelan CJ. Inhibition of PAF-, LPS-, and cytokine-induced granulocyte accumulation in guinea pig lung by dexamethasone: evidence that inhibition of IL-5 release is responsible for the selective inhibition of eosinophilia by glucocorticoids in guinea pigs. Inflamm. Res. 1996;45: 166-170.
35. Uno T, Tanaka H, Nagai H. Effects of isoenzyme selective phosphodiesterase inhibitors on bacterial lipopolysaccharide-induced bronchial hyperreactivity in guinea pigs. Gen. Pharmac. 1998;30:167-173.
36. Howell EH, Jenkins LP, Howell DA. Inhibition of lipopolysaccharide- induced pulmonary edema by isozyme-selective phosphodiesterase inhibitors in guinea pigs. J. Pharmacol. Exp. Ther 1995;275:703-709.
37. Escofier N, Boichot E, Germain N, Silva PMR, Martins MA, Lagente V. Effects of interleukin-10 and modulators of cyclic AMP formation on endotoxin-induced inflammation in rat lung. Fundam. Clin. Pharmacol. 1999;13:96-101.
38. Beckmann N, Tigani B, Sugar R et al. Noninvasive detection of endotoxin-induced mucus hypersecretion in rat lung by MRI. Am. J. Physiol. Lung Cell Mol. Physiol. 2002; 283:22-30.
39. Kumar RK, Herbert C, Thomas PS et al. Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma. J. Pharmacol. Exp. Ther. 2003;307:349-355.
40. Sun JG, Deng YM, Wu X et al. Inhibition of phosphodiesterase activity, airway inflammation and hyperresponsiveness by PDE4 inhibitor and glucocorticoid in a murine model of allergic asthma. Life Sci. 2006;79:2077-2085.
41. Yano Y, Yoshida M, Hoshino S et al. Anti-fibrotic effects of theophylline on lung fibroblasts. Biochem. Biophys. Res. Commun. 2006;34:684-690.
42. Yao PL, Tsai MF, Lin YC et al. Global expression profiling of theophylline response genes in macrophages: evidence of airway anti-inflammatory regulation. Respir. Res. 2005; 6:89.
43. Pauwels RA, Joos GF. Characterization of the adenosine receptors in the airways. Arch. Int. Pharmacodyn. 1995; 329:151-160.
44. Ichiyama T, Hasegawa S, Matsubara T, Hayashi T, Furukawa S. Theophylline inhibits NF-kappa B activation and I kappa B alpha degradation in human pulmonary epithelial cells. Naunyn. Schmiedebergs. Arch. Pharmacol. 2001;364:558-561.
45. Anderson R, Goolam Mahomed A, Theron AJ, Ramafi G, Feldman C. Effect of rolipram and dibutyryl cyclic AMP on resequestration of cytosolic calcium in FMLP-activated human neutrophils. Br. J. Pharmacol. 1998;124:547- 555.
46. van Furth AM, Seijmonsbergen EM, Langermans JA, van der Meide PH, van Furth R. Effect of xanthine derivates and dexamethasone on Streptococcus pneumoniae-stimulated production of tumor necrosis factor alpha, interleukin-1 beta (IL-1 beta), and IL-10 by human leukocytes. Clin. Diagn. Lab. Immunol. 1995;2:689-692.